Aidarex Pharmaceuticals LLC

Aidarex Pharmaceuticals LLC (United States) has no DMF, CEP or site registration linked in our records. 17 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Aidarex Pharmaceuticals LLC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/aidarex-pharmaceuticals-llc

Overview

Aidarex Pharmaceuticals LLC is a privately-held company specializing in the distribution and marketing of pharmaceutical products. The company focuses on providing cost-effective healthcare solutions to a diverse clientele.

Therapeutic areas

FDA compliance signals

17 FDA enforcement records linked to this company.

  • recall — Class III2018-08-01

    Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

  • recall — Class III2018-08-01

    Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

  • recall — Class III2018-08-01

    Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

  • recall — Class III2018-05-23

    Presence of Foreign Tablets/Capsules

  • recall — Class III2017-11-01

    Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.

  • 4832017-10-20

    Results not used for expiration dates, storage cond.

  • recall — Class III2017-09-20

    Failed Impurities/Degradation Specification; out-of-specification results for individual unknown impurities at the 30 month Room Temperature Retained Sample stability test

  • recall — Class III2016-07-06

    Failed Impurities/Degradation Specifications: Out of specification results for unknown impurity.

  • recall — Class III2016-06-15

    CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.

  • recall — Class II2016-06-15

    Failed Impurity/Degradation Specifications: Out of specifications for unknown impurity.

  • recall — Class II2014-10-29

    Presence of Foreign Tablets/Capsules: Tramodol 50 mg tablet has been found in a bottle of Ciprofloxacin 500 mg

  • 4832012-02-22

    Mfg / Processing Operations Area

  • 4832012-02-22

    Equipment for Environmental Control

  • 4832012-02-22

    Cleaning / Sanitizing / Maintenance

  • 4832012-02-22

    Failing to test for penicillin cross-contamination

  • 4832012-02-22

    Equipment Design, Size and Location

  • 4832012-02-22

    Absence of Written Procedures

For suppliers

Is this Aidarex Pharmaceuticals LLC?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.